Stockreport

Potential of ADX-629 in COVID-19 lifts Aldeyra, up 14% premarket [Seeking Alpha]

Aldeyra Therapeutics, Inc.  (ALDX) 
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com/investor-relations
PDF Thinly traded nano cap Aldeyra Therapeutics (NASDAQ:ALDX14%In 85 healthy volunteers, orally administered ADX-629 was well-tolerated with no treatment-related adverse eve [Read more]